Healthcare Infection Control Practices Advisory Committee (HICPAC), 66383 [2014-26511]

Download as PDF Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2014–26510 Filed 11–6–14; 8:45 am] [FR Doc. 2014–26511 Filed 11–6–14; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: mstockstill on DSK4VPTVN1PROD with NOTICES 9:00 a.m.–5:00 p.m., December 4, 2014 9:00 a.m.–12:00 p.m., December 5, 2014 Place: Emory Conference Center, The Silverbell Pavilion, 1615 Clifton Rd, Atlanta, Georgia, 30329. Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include updates on CDC’s activities for prevention of healthcare associated infections (HAIs), updates on antimicrobial resistance, an update on Draft Guidelines, and updates on healthcare preparedness and emerging infections. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639–4045. Email: hicpac@cdc.gov The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and 19:12 Nov 06, 2014 Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget (OMB) the following requirements for emergency review. This is necessary to ensure compliance with an initiative of the Administration. We are requesting an emergency review under 5 CFR Part 1320(a)(2)(i) because public harm is reasonably likely to result if the normal clearance procedures are followed. We are seeking emergency approval for modifications to the information collection request (ICR) SUMMARY: Times and Dates VerDate Sep<11>2014 [Document Identifiers: CMS–10371] Jkt 235001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 66383 currently approved under Office of Management and Budget (OMB) control number 0938–1119 in order to collection additional information during the 2015 open enrollment periods from the 14 operational SBMs (including Washington, DC) to enhance the agency’s understanding of the demographic makeup of the citizens enrolling in the various health plans as well as the affordability of those plans. Existing collections gather information from the grant awardee to ensure the CMS is able to conduct their statutory oversight responsibilities. The revision to the weekly reporting requirement is necessary to obtain more accurate and consistent enrollment data during the upcoming Open Enrollment Period which begins November 15, 2014. The immediate need for this revision is due to the State-Based Marketplaces (SBM) maturing business processes and the requirement for more precise reporting of comparison data between the first and second years of ACA implementation. The changes to the revised format of the Weekly Report have been presented to all participating states. CMS is requesting an emergency modification to the weekly reporting template in order to capture certain demographic data and information on new versus re-enrolled individuals in accordance with uniform definitions so as not to produce misleading results. Comments must be received by November 14, 2014. DATES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to http:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: CMS–10371/OMB Control Number 0938–1119, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following ADDRESSES: E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 79, Number 216 (Friday, November 7, 2014)]
[Notices]
[Page 66383]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26511]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

Times and Dates

9:00 a.m.-5:00 p.m., December 4, 2014
9:00 a.m.-12:00 p.m., December 5, 2014

    Place: Emory Conference Center, The Silverbell Pavilion, 1615 
Clifton Rd, Atlanta, Georgia, 30329.
    Status: Open to the public, limited only by the space available. 
Please register for the meeting at www.cdc.gov/hicpac.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, 
the Director, National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), the Director, CDC, the Secretary, Health and 
Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related 
events in settings where healthcare is provided; and (3) periodic 
updating of CDC guidelines and other policy statements regarding 
prevention of healthcare-associated infections and healthcare-
related conditions.
    Matters for Discussion: The agenda will include updates on CDC's 
activities for prevention of healthcare associated infections 
(HAIs), updates on antimicrobial resistance, an update on Draft 
Guidelines, and updates on healthcare preparedness and emerging 
infections.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton 
Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-
4045. Email: hicpac@cdc.gov
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2014-26511 Filed 11-6-14; 8:45 am]
BILLING CODE 4163-18-P